Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-β, and CTLA4Ig)

Journal of Leukocyte Biology

Volumn 66, Issue 2, 1999, Pages 293-296

  Lu, Lina ^a   Lee, Wei Chen ^b   Takayama, Takuya ^b   Qian, Shiguang ^b   Gambotto, Andrea ^b   Robbins, Paul D ^b   Thomson, Angus W ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Gene therapy; Immunosuppression

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0032797186     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.2.293     Document Type: Article

References (31)

1. Steinman, R. M. (1991) The dendritic cell system and its role in immunogenicily. Annu. Rev. Immunol. 9, 271-296.
2. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
3. Matzinger, P., Guerder, S. (1989) Does T-cell tolerance require a dedicated antigen presenting cell? Nature 338, 74-76.
4. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplant. 60, 1539-1545.
5. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplant. 62, 659-665.
6. Rastellini, C., Lu, L., Ricordi, C., Starzl, T. E., Rao, A. S., Thomson, A. W. (1995) GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplant. 60, 1366-1370.
7. Suzuki, T., Tahara, H., Narula, S., Moore, K. W., Robbins, P. D., Lotze, M. T. (1995) Viral interleukin-10 (IL-10), human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182, 477-486.
8. Lu, L., Bonham, C. A., Chambers, F. G., Watkins, S. C., Hoffman, R. A., Simmons, R. L., Thomson, A. W. (1996) Induction of nitric oxide synthase in mouse dendritic cells by interferon-γ, endotoxin and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol. 157, 3577-3586.
9. Süss, G., Shortman K. (1996) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand induced apoptosis. J. Exp. Med. 183, 1789-1796.
10. Lu, L., Qian, S., Hershberger, P., Rudert, W. A., Lynch, D. H., Thomson, A. W. (1997) Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158, 5676-5684.
11. Khoury, S. J., Gallon, L., Verburg, R. R., Chandraker, A., Peach, R., Linsley, P. S., Turka, L. A., Hancock, W. W., Sayegh, M. H. (1995) Ex-vivo treatment of antigen-presenting cells with CTLA4-Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 157, 3700-3705.
12. Morikawa, Y., Tohya, K., Matsuura, N., Kakudo, K. (1995) Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice. Immunol. 85, 575-581.
13. Mosmann, T. R. (1994) Interleukin-10. In The Cytokine Handbook, 2nd ed. (A. W. Thomson, ed.) San Diego, CA: Academic Press, 223-237.
14. De Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.-G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., de Vries, J. E. (1991) Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.
15. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O., Moser, M. (1997) Effects of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27, 1229-1235.
16. De Waal Malefyt, R., Moore, K. W. (1998) Interleukin-10. In The Cytokine Handbook, 3rd ed., (A. W. Thomson, ed.) San Diego, CA: Academic Press, 333-364.
17. Qin, L., Chavin, K. D., Ding, Y., Tahara, H., Favaro, J. P., Woodward, J. E., Suzuki, T., Bobbins, P. D., Lotze, M. T., Bromberg, J. S. (1996) Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156, 2316-2323.
18. Demidem, A., Taylor, J. R., Grammer, S. F., Streilein, J. W. (1991) Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. J. Invest. Dermatol. 96, 401-407.
19. Raju. G. P., Belland, S. E., Eisen, H. J. (1994) Prolongation of cardiac allograft survival with transforming growth factor-β1 in rats. Transplant. 58, 392-396.
20. Verbanac, K. M., Carver F. M., Haisch, C. E., Thomas, J. M. (1994) A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplant. 57, 893-900.
21. Bonham, C. A., Lu, L., Banas, H. A., Fontes, P., Rao, A. S., Zeevi, A., Thomson, A. W. (1996) TGF-β pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transplant. Immunol. 4, 186-191.
22. Lu, L., Li, W., Fu, F., Chambers, F. G., Qian, S., Fung, F., Thomson, A. W. (1997) Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transp ant. 64, 1808-1815.
23. Linsley, P. S., Ledbetter, J. A. (1593) The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
24. Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., Larsen, C. P. (1994) Transplantation tolerance induced by CTLA4-Ig. Transplant. 57, 1701-1706.
25. Verberg, R., Chandraker, A., Gallohn, L., Hancock, W. W., Sayegh, M. H., Khoury, S. J. (1996) Ex-vivo treatment of antigen-presenting cells with CTLAIg and peptide prevents EAE in the Lewis rat. J. Immunol. 157, 3700-3705.
26. Lee, W. C., Zhong, C., Qian, S., Wan, Y., Gauldie, J., Mi, B., Robbins, P. D., Thomson, A. W., Lu, L. (1998) Phenotype function and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β. Transplant. 66, 1810-1817.
27. Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., Hwu, P. (1997) Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective againast established pulmonary metastases. J. Exp. Med. 186, 1213-1221.
28. Song, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A. S., Crystal, R. G. (1997) Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247-1256.
29. Aicher, A., Westermann, J., Cayeux, S., Willimsky, G., Daemen, K., Blankenstein, T., Uckert, W., Dorken, B., Pezzutto, A. (1997) Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25, 39-44.
30. Takayama, T., Nishioka, Y., Lu., L., Lotze, M. T., Tahara, H., Thomson, A. W. (1998) Retroviral delivery of viral IL-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T cell hyporesponsiveness. Transplant. 66, 1567-1574.
31. Lu, L., Gambotto, A., Lee, W-C. Qian, S., Bonham, C. A., Robbins, P. D., Thomson, A. W. (1999) Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther., in press.